Keratitis, an inflammation of the cornea caused by bacterial or fungal infections, is one of the
leading causes of severe visual disability and blindness. Keratitis treatment requires both …

Bacterial keratitis (BK) is an ophthalmic infection caused by bacteria and poses a risk of
blindness. Numerous drugs have been used to treat BK, the majority suffered from limited …

Bacteria‐induced keratitis is a major cause of corneal blindness in both developed and
developing countries. Instillation of antibiotic eyedrops is the most common management of …

Pseudomonas aeruginosa infection is a severe acute suppurative ulcer that engulfs virtually
the entire tissue in a short period and leads to devastating destruction. Antibiotic therapy is a …

Fungal keratitis is challenging to diagnose and treat and remains a significant cause of
blindness worldwide. The easiest and most common method of drug delivery for patients …

Developing a potential alternative with safe, minimally invasive, and highly effective
antimicrobial properties is significant for treating bacterial keratitis. In this paper, we present …

Methicillin‐resistant Staphylococcus aureus (MRSA) biofilm‐associated bacterial keratitis is
highly intractable, with strong resistance to β‐lactam antibiotics. Inhibiting the MRSA …

Fungal keratitis is the primary cause of infectious corneal blindness in China. Currently,
early-stage treatment mainly involves the frequent administration of antifungal medications …

Intraocular inflammation seriously impairs vision, and the effectiveness of intraocular drug
delivery is hampered by various physiological barriers, such as the corneal barrier. In this …

Bacterial keratitis (BK) is a leading cause of visual impairment. The fluoroquinolone
antibiotic moxifloxacin (Mox), being highly water-soluble, suffers from poor corneal …